RS
RSW.LSE Renishaw PLC
- Market cap
- GBX 3.83B
- P/E
- 32.3x
- P/B
- 3.87x
- ROE
- 12.1%
- Dividend yield
- 1.56%
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Jun 2026.
Is RSW.LSE undervalued?
Graham numberRSW.LSE trades 135.9% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Renishaw PLC fundamental analysis
No fundamental analysis for Renishaw PLC yet.
Renishaw PLC stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Renishaw PLC
Renishaw plc, an engineering and scientific technology company, designs, manufactures, distributes, sells, and services technological products and services, and analytical instruments and medical devices worldwide. The company operates through three segments: Industrial Metrology, Position Measurement, and Specialised Technologies. It offers precision measurement and process control products, such as co-ordinate measuring machine probes, software, retrofits, equator gauging …
Full company profileRenishaw PLC financial statements
Renishaw PLC annual financial statements (GBP; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 537M | 612M | 574M | 509M | 567M | 674M | 689M | 691M | 713M | 816M |
| Gross Profit | 285M | 327M | 284M | 325M | 370M | 439M | 434M | 422M | 331M | 484M |
| Operating Income | 119M | 149M | 97.9M | 57.4M | 138M | 143M | 134M | 109M | 108M | 134M |
| EBITDA | 146M | 198M | 150M | 48.4M | 172M | 174M | 166M | 156M | 143M | 167M |
| Net Income | 89.0M | 133M | 92.2M | 288K | 111M | 120M | 116M | 96.9M | 83.8M | 119M |
| EPS | 1.22 | 1.83 | 1.27 | 0.00 | 1.53 | 1.65 | 1.60 | 1.33 | 1.15 | 1.64 |
| Balance Sheet | ||||||||||
| Total Assets | 630M | 742M | 776M | 766M | 857M | 993M | 1.04B | 1.05B | 1.14B | 1.23B |
| Total Liabilities | 186M | 193M | 193M | 220M | 154M | 178M | 147M | 149M | 209M | 242M |
| Shareholders' Equity | 444M | 549M | 584M | 547M | 704M | 816M | 897M | 903M | 926M | 985M |
| Cash & Short-term Investments | 51.9M | 104M | 107M | 131M | 215M | 253M | 206M | 218M | 274M | 291M |
| Total Debt | - | - | 10.4M | 24.7M | 20.0M | 16.3M | 13.3M | 18.5M | 15.6M | 13.5M |
| Cash Flow | ||||||||||
| Operating Cash Flow | 115M | 132M | 106M | 105M | 135M | 121M | 84.3M | 124M | 148M | 121M |
| Capital Expenditure | 42.6M | 34.9M | 56.8M | 59.4M | 23.7M | 39.7M | 84.9M | 74.8M | 46.3M | 38.3M |
| Free Cash Flow | 72.6M | 97.3M | 49.7M | 45.3M | 112M | 81.8M | -554K | 49.3M | 102M | 83.0M |
| Ratios | ||||||||||
| ROE | 20.0% | 24.2% | 15.8% | 0.1% | 15.8% | 14.8% | 12.9% | 10.7% | 9.0% | 12.1% |
| ROA | 14.1% | 17.9% | 11.9% | 0.0% | 13.0% | 12.1% | 11.1% | 9.2% | 7.4% | 9.7% |
| Net Profit Margin | 16.6% | 21.7% | 16.1% | 0.1% | 19.6% | 17.9% | 16.9% | 14.0% | 11.7% | 14.6% |
| Debt to Equity | - | - | 0.02x | 0.05x | 0.03x | 0.02x | 0.01x | 0.02x | 0.02x | 0.01x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Renishaw PLC dividends
- Dividend yield
- 1.56%
- Forward dividend
- 0.82 GBX
- Payout ratio
- 47.8%
- Ex-dividend date
- Oct 29, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2026 | GBP 56.8M | 0.78 | 47.8% |
| 2025 | GBP 55.4M | 0.76 | 66.2% |
| 2024 | GBP 55.4M | 0.76 | 57.2% |
| 2023 | GBP 53.4M | 0.73 | 46.0% |
| 2022 | GBP 49.5M | 0.68 | 41.1% |
| 2021 | GBP 10.2M | 0.14 | 9.1% |
| 2020 | GBP 33.5M | 0.46 | 11,624.3% |
| 2019 | GBP 43.7M | 0.60 | 47.4% |
| 2018 | GBP 38.9M | 0.54 | 29.3% |
| 2017 | GBP 34.9M | 0.48 | 39.3% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 6:5 on Nov 25, 1996.
Who owns Renishaw PLC
- Insiders 51.57%
- Institutions 39.71%
- Public & others 8.72%
- Shares outstanding 72.8M
- Free float 35.8M
Renishaw PLC company profile
- Company name
- Renishaw PLC
- Ticker
- RSW.LSE
- ISIN
- GB0007323586
- Exchange
- London Exchange
- Sector
- Technology
- Industry
- Electronic Equipment, Instruments & Components
- Employees
- 5,254
- Fiscal year end
- June
- Address
- New Mills, Wotton-under-Edge, United Kingdom, GL12 8JR
- Phone
- 44 1453 524 524
- Website
- renishaw.com
About Renishaw PLC
Renishaw plc, an engineering and scientific technology company, designs, manufactures, distributes, sells, and services technological products and services, and analytical instruments and medical devices worldwide. The company operates through three segments: Industrial Metrology, Position Measurement, and Specialised Technologies. It offers precision measurement and process control products, such as co-ordinate measuring machine probes, software, retrofits, equator gauging systems, fixtures, machine calibration and optimization, machine tool probes, precision styli for metrology, and smart manufacturing data platform; and position and motion control products comprising interferometric laser, magnetic, and optical encoders. The company also provides healthcare products, such as neuromate stereotactic robots, neuroinfuse drug delivery systems, neuroinspire surgical planning software, dixi medical's, and Raman spectrometers; industrial robots; and metal additive 3D printing manufacturing systems. It serves the aerospace, automotive, consumer electronics, medical and healthcare, heavy, machine builder, energy, and precision manufacturing industries, as well as scientific, research, and analysis industries. The company was incorporated in 1973 and is based in Wotton-under-Edge, the United Kingdom.
Renishaw PLC management
10- Mr. William Ernest Lee M.A., M.B.A.CEO & Director · born 1975
- Mr. Daniel John DeerCo-Founder & Non-Executive Director · born 1938
- Mr. John Francis ShipseyCFO & Executive Director · born 1964
- Mr. Dave WallaceDirector of Group Operations · born 1971
- Mr. Kasim Ali HussainGroup General Counsel & Company Secretary
- Mr. Chris PockettHead of External Communications
- Ms. Clare NichollsGroup Human Resources Director
- Mr. Rainer LotzPresident of EMEA · born 1965
- Andy ButtreyPresident of APAC
- Mr. Rupert JonesManaging Director of Renishaw Medical